AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Nov 13, 2018
29821_dirs_2018-11-13_2dc80c34-b6f8-4bb7-911d-0375993cd933.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-11-09
Reporting Person: Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-09 | Common Stock | M | 23458.0000 | $8.3000 | Acquired | 137639.9900 | Direct |
| 2018-11-09 | Common Stock | S | 23458.0000 | $37.5090 | Disposed | 114181.9900 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-09 | Stock Option (Right to Buy) | $8.3000 | M | 23458.0000 | Disposed | 2019-02-24 | Common Stock (23458.0000) | Direct |
Footnotes
F1: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.545, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Grant to the reporting person of an option to purchase a specified number of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.